Hitomi Kurinami

2.3k total citations
38 papers, 1.9k citations indexed

About

Hitomi Kurinami is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Hitomi Kurinami has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Physiology and 8 papers in Surgery. Recurrent topics in Hitomi Kurinami's work include Alzheimer's disease research and treatments (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Computational Drug Discovery Methods (5 papers). Hitomi Kurinami is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Computational Drug Discovery Methods (5 papers). Hitomi Kurinami collaborates with scholars based in Japan, France and United States. Hitomi Kurinami's co-authors include Ryuichi Morishita, Naoyuki Sato, Munehisa Shimamura, Hiromi Rakugi, Daisuke Takeuchi, Shuko Takeda, Mitsuru Shinohara, Toshio Ogihara, Kozue Uchio‐Yamada and Jun Wada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Hitomi Kurinami

38 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitomi Kurinami Japan 25 668 600 372 311 213 38 1.9k
Jenq‐Lin Yang Taiwan 28 520 0.8× 1.0k 1.7× 373 1.0× 370 1.2× 254 1.2× 53 2.3k
Tsunehiko Ikeda Japan 31 287 0.4× 1.0k 1.7× 325 0.9× 251 0.8× 219 1.0× 247 3.5k
Libang Yang United States 16 627 0.9× 635 1.1× 287 0.8× 212 0.7× 258 1.2× 31 1.7k
Shinn‐Zong Lin Taiwan 28 253 0.4× 1.1k 1.8× 303 0.8× 617 2.0× 223 1.0× 160 2.8k
Benjamin Pulli United States 20 408 0.6× 430 0.7× 320 0.9× 240 0.8× 112 0.5× 53 2.0k
Yoichi Morofuji Japan 20 294 0.4× 427 0.7× 557 1.5× 160 0.5× 197 0.9× 120 1.8k
Jena J. Steinle United States 30 264 0.4× 1.5k 2.5× 265 0.7× 353 1.1× 157 0.7× 125 2.9k
D. Gambi Italy 31 549 0.8× 762 1.3× 700 1.9× 652 2.1× 194 0.9× 106 3.1k
Hai-dong Guo China 25 360 0.5× 1.3k 2.2× 367 1.0× 217 0.7× 314 1.5× 61 2.6k
Ádám Nyúl‐Tóth Hungary 32 581 0.9× 680 1.1× 857 2.3× 110 0.4× 89 0.4× 68 2.6k

Countries citing papers authored by Hitomi Kurinami

Since Specialization
Citations

This map shows the geographic impact of Hitomi Kurinami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Kurinami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Kurinami more than expected).

Fields of papers citing papers by Hitomi Kurinami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitomi Kurinami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Kurinami. The network helps show where Hitomi Kurinami may publish in the future.

Co-authorship network of co-authors of Hitomi Kurinami

This figure shows the co-authorship network connecting the top 25 collaborators of Hitomi Kurinami. A scholar is included among the top collaborators of Hitomi Kurinami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitomi Kurinami. Hitomi Kurinami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isaka, M., Ken Sugimoto, Taku Fujimoto, et al.. (2020). The utility of the ultrasonographic assessment of the lower leg muscles to evaluate sarcopenia and muscle quality in older adults. SHILAP Revista de lepidopterología. 6(2). 53–61. 4 indexed citations
2.
Nakamaru, Ryo, Kōichi Yamamoto, Satoko Nozato, et al.. (2019). A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling. SHILAP Revista de lepidopterología. 7(10). 1895–1899. 2 indexed citations
3.
Isaka, M., Ken Sugimoto, Hiroshi Akasaka, et al.. (2019). The Usefulness of an Alternative Diagnostic Method for Sarcopenia Using Thickness and Echo Intensity of Lower Leg Muscles in Older Males. Journal of the American Medical Directors Association. 20(9). 1185.e1–1185.e8. 38 indexed citations
4.
Fujimoto, Taku, Ken Sugimoto, Toshimasa Takahashi, et al.. (2019). Overexpression of Interleukin-15 exhibits improved glucose tolerance and promotes GLUT4 translocation via AMP-Activated protein kinase pathway in skeletal muscle. Biochemical and Biophysical Research Communications. 509(4). 994–1000. 27 indexed citations
5.
Nakagami, Hironori, Hiroshi Koriyama, H. Tomioka, et al.. (2013). Development of novel DNA vaccine for VEGF in murine cancer model. Scientific Reports. 3(1). 3380–3380. 15 indexed citations
6.
Shimamura, Munehisa, Ping Zhou, Barbara Casolla, et al.. (2013). Prostaglandin E2 Type 1 Receptors Contribute to Neuronal Apoptosis after Transient Forebrain Ischemia. Journal of Cerebral Blood Flow & Metabolism. 33(8). 1207–1214. 32 indexed citations
7.
Nakagami, Hironori, Hiroshi Koriyama, Futoshi Nakagami, et al.. (2013). Inhibition of Neointima Formation through DNA Vaccination for Apolipoprotein(a): A New Therapeutic Strategy for Lipoprotein(a). Scientific Reports. 3(1). 1600–1600. 6 indexed citations
8.
Kurinami, Hitomi, Munehisa Shimamura, Naoyuki Sato, Hironori Nakagami, & Ryuichi Morishita. (2013). Do Angiotensin Receptor Blockers Protect Against Alzheimer’s Disease?. Drugs & Aging. 30(6). 367–372. 16 indexed citations
9.
Takeda, Shuko, Naoyuki Sato, Kozue Uchio‐Yamada, et al.. (2010). Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes. Proceedings of the National Academy of Sciences. 107(15). 7036–7041. 407 indexed citations
10.
Sato, Naoyuki, Hitomi Kurinami, Daisuke Takeuchi, et al.. (2010). Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance. Journal of Biological Chemistry. 285(29). 22091–22102. 99 indexed citations
11.
Takeda, Shuko, Naoyuki Sato, Kazue Niisato, et al.. (2009). Validation of Aβ1–40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. Brain Research. 1280. 137–147. 49 indexed citations
12.
Takeuchi, Daisuke, Naoyuki Sato, Munehisa Shimamura, et al.. (2008). Alleviation of Aβ-induced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model. Gene Therapy. 15(8). 561–571. 33 indexed citations
13.
Sato, Naoyuki, Munehisa Shimamura, Daisuke Takeuchi, et al.. (2007). Gene therapy for ischemic brain disease with special reference to vascular dementia. Geriatrics and gerontology international. 7(1). 1–14. 1 indexed citations
14.
Sato, Naoyuki, Masayasu Okochi, Yoshiaki Taniyama, et al.. (2006). Development of new screening system for Alzheimer disease, in vitro Aβ sink assay, to identify the dissociation of soluble Aβ from fibrils. Neurobiology of Disease. 22(3). 487–495. 6 indexed citations
15.
Aoki, Motokuni, Ryuichi Morishita, Hirofumi Makino, et al.. (2005). Clinical Trial of Human Gene Therapy Using Hepatocyte Growth Factor Gene Transfer(Translational Research in Cardiovascular Disease, The 69th Annual Scientific Meeting of the Japanese Circulation Society). Japanese Circulation Journal-english Edition. 69. 22. 1 indexed citations
16.
Shimamura, Munehisa, Naoyuki Sato, Yoshiaki Taniyama, et al.. (2005). Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles. The Journal of Gene Medicine. 7(11). 1468–1474. 45 indexed citations
17.
Shimamura, Munehisa, Naoyuki Sato, Kazuo Oshima, et al.. (2004). Novel Therapeutic Strategy to Treat Brain Ischemia. Circulation. 109(3). 424–431. 96 indexed citations
18.
Furuyama, Tatsuo, et al.. (2004). Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurones. Genes to Cells. 9(9). 821–829. 68 indexed citations
19.
Makino, Hirofumi, Motokuni Aoki, Naotaka Hashiya, et al.. (2004). Increase in Peripheral Blood Flow by Intravenous Administration of Prostaglandin E1 in Patients with Peripheral Arterial Disease, Accompanied by Up-Regulation of Hepatocyte Growth Factor. Hypertension Research. 27(2). 85–91. 24 indexed citations
20.
Inagaki, Shinobu, et al.. (2001). Sema4C, a Transmembrane Semaphorin, Interacts with a Post-synaptic Density Protein, PSD-95. Journal of Biological Chemistry. 276(12). 9174–9181. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026